DK0486395T3 - Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin - Google Patents

Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin

Info

Publication number
DK0486395T3
DK0486395T3 DK91403059.8T DK91403059T DK0486395T3 DK 0486395 T3 DK0486395 T3 DK 0486395T3 DK 91403059 T DK91403059 T DK 91403059T DK 0486395 T3 DK0486395 T3 DK 0486395T3
Authority
DK
Denmark
Prior art keywords
cyclodextrin
hydroxypropyl
beta
retinoic acid
aqueous gel
Prior art date
Application number
DK91403059.8T
Other languages
Danish (da)
English (en)
Inventor
Alain Rolland
Braham Shroot
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Application granted granted Critical
Publication of DK0486395T3 publication Critical patent/DK0486395T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91403059.8T 1990-11-15 1991-11-14 Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin DK0486395T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87843A LU87843A1 (fr) 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique

Publications (1)

Publication Number Publication Date
DK0486395T3 true DK0486395T3 (da) 1995-04-24

Family

ID=19731263

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91403059.8T DK0486395T3 (da) 1990-11-15 1991-11-14 Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin

Country Status (8)

Country Link
EP (1) EP0486395B1 (de)
JP (1) JP2650805B2 (de)
AT (1) ATE113831T1 (de)
CA (1) CA2055578A1 (de)
DE (1) DE69105094T2 (de)
DK (1) DK0486395T3 (de)
ES (1) ES2064958T3 (de)
LU (1) LU87843A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2047456B1 (es) * 1992-07-31 1994-10-01 Herrando Carlos Postigo Composicion para la obtencion de un producto cosmetico y productos similares.
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
ES2083333B1 (es) * 1994-09-22 1997-01-16 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.
IL131543A (en) 1997-02-25 2005-08-31 Univ Michigan Cosmetic methods and compositions for preventing and treating chronological aging in human skin
US6183729B1 (en) * 1997-05-02 2001-02-06 Cosmoferm B.V. Stable vitamin C concentrates
EP1109581A1 (de) * 1998-09-02 2001-06-27 Allergan Sales, Inc. Geschützte cyclodextrin-enthaltende zusammensetzungen
MXPA05005170A (es) * 2002-12-12 2005-10-05 Galderma Res & Dev Gel despigmentante alcoholico acuoso que contiene un derivado fenolico y un retinoide.
JP4781680B2 (ja) * 2005-01-17 2011-09-28 株式会社Ａｄｅｋａ 防腐剤組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Also Published As

Publication number Publication date
EP0486395B1 (de) 1994-11-09
JPH0656622A (ja) 1994-03-01
ES2064958T3 (es) 1995-02-01
EP0486395A1 (de) 1992-05-20
LU87843A1 (fr) 1992-08-25
JP2650805B2 (ja) 1997-09-10
ATE113831T1 (de) 1994-11-15
CA2055578A1 (fr) 1992-05-16
DE69105094D1 (de) 1994-12-15
DE69105094T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
DE69733687D1 (de) Kosmetische zusammensetzung fuer hautregenerierung ohne hautreizung
EP0068552A3 (de) Topisches mikrobizides Präparat
FR2768927B1 (fr) Utilisation de l'acide ellagique, de ses sels, de ses complexes metalliques, de ses derives mono- ou poly-ethers, mono- ou poly-acyles dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie
ES2130307T3 (es) Preparados cosmeticos y dermatologicos con un contenido en acido delta-aminolevulinico.
ATE109964T1 (de) Kosmetisches präparat.
NO302274B1 (no) Anvendelse av 9-cis retinsyre
RU93005355A (ru) Фармакологические композиции
MY105521A (en) Moisturizing vehicle for topical application of vitamin a acid.
EP0875241A3 (de) Wässrige, kosmetische Zusammensetzung enthaltend, stabile solubilisierte Harnsäure, und wasserlösliches Polymer, und Verfahren zur stabilen Solubilisierung von Harnsäure in einer wässrigen, kosmetischen Zusammensetzung
DK0486395T3 (da) Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin
DE69419981D1 (de) Retinoid enthaltendes Mittel
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
WO2004030605A3 (fr) Formulations cosmetiques a base d'un agent gelifiant et/ou epaississant et leurs applications
DK0727996T3 (da) Fendazolformuleringer
ATE160088T1 (de) Topische wässrige gele oder suspension auf basis von pulverisiertem vulkanischen oder diagenischem minerale
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
FR2416009A1 (fr) Substance cosmetique active a base de proteines de la peau
ES2047674T3 (es) Composicion cosmetica.
FI910112A0 (fi) Preparat foer lokalt bruk.
NO902104L (no) Kosmetisk blanding.
EP0968707A3 (de) Gegen Akne und entzündete Comedonen wirksame Zubereitungen enthaltend Serin-Proteasen und ein oder mehrere Calciumsalze
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
KR910021235A (ko) 탈색 및 광노화방지 활성을 갖는 피부학적 조성물
ES2106689A1 (es) Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
DK0457521T3 (da) Neglelakfjerner